IPO WATCH- Is emerging markets private equity giant Abraaj looking to list its Middle East healthcare subsidiaries in London or New York? The Abraaj Group is reportedly mulling the London Stock Exchange and the New York Stock Exchange as venues on which to list its Middle East healthcare investments, according to Al Borsa in a transaction that could take place as early as 2Q2018. EFG Hermes has reportedly been tapped to manage to the transaction, the newspaper says. The firm’s North African healthcare investments include Egypt’s Cleopatra Hospitals Group as well as players in Morocco and Tunisia. This wouldn’t be the first time Abraaj has looked abroad to list a regional healthcare group: It listed Integrated Diagnostics Holdings in London in 2015 after first creating the group through the merger of two high-profile Egyptian labs and the bolt-on of assets in Sudan and Jordan. You can review Abraaj’s healthcare portfolio companies here and learn more about its views on the sector here.

Tags: